TOP 20 Biotechnology VC Deals

Today Fierce Biotechnology Published report on TOP 20 VC deals. Following were included

1. Clovis Oncology - $146.30 million
2. Zogenix - $70.96 million
3. BioVex Group - $70 million
4. Pacific Biosciences - $68 million
5. Hyperion Therapeutics - $68 million
6. Anacor Pharmaceuticals $50 million
6. Proteon Therapeutics $50 million
6. PTC Therapeutics $50 million
9. Virdante Pharmaceuticals - $47.75 million
10. Cempra Pharmaceuticals - $46 million
11. Complete Genomics - $45 million
11. SFJ Pharmaceuticals - $45 million
13. Amyris Biotechnologies - $41.75 million
14. Kolltan Pharmaceuticals - $40.50 million
15. Ironwood Pharmaceuticals - $40 million
15. Epizyme - $40 million
15. Adamas Pharmaceuticals - $40 million
15. Aileron Therapeutics - $40 million
15. Regado Biosciences - $40 million
20. GlycoMimetics - $38.98 million

Major Venture capital funding was in cancer, then there were many inflammation, malaria, neural disorders and blood disorders and two of the venture funding out of 20 were for gene sequencing.

Read more: http://www.fiercebiotech.com/special-reports/top-20-biotech-venture-capital-deals-2009?utm_medium=nl&utm_source=internal#ixzz0gaW1X3fa